Ozempic and Wegovy Prompts Asset Owners to Rethink Restaurant and Food Investments in the US
Posted on 02/08/2024
Novo Nordisk’s weight-loss drugs Ozempic and Wegovy are creating fear for food manufacturers. Companies including Nestlé and Conagra Brands could alter their product lineups. Globally speaking, Nestle’s biggest businesses are coffee and pet care. Even restaurant investments are experiencing possibilities of being sold. San Francisco-based Flynn Group is a major franchisee operator of restaurants and…
